{
  "docId": "019de074-48ca-708b-9817-9b094467f30f",
  "docSlug": "b3581031b12373a5077a05b88a8907f5",
  "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 45,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": "The slide uses a 2x2 grid for metrics and a list for pipeline examples.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-48ca-708b-9817-9b094467f30f/6",
  "deckHref": "/decks/019de074-48ca-708b-9817-9b094467f30f",
  "deckJsonHref": "/decks/019de074-48ca-708b-9817-9b094467f30f.json",
  "deckAnchorHref": "/decks/019de074-48ca-708b-9817-9b094467f30f#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.45,
        "x": 0.5,
        "y": 0.42
      },
      "kind": "list",
      "text": "camizestrant, volrustomig/rilvegostomig, baxdrostat, ALXN1850",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8d212725-c173-4e8c-ad17-e2a5d4c0770b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.5,
        "y": 0.28
      },
      "kind": "list",
      "text": "Initiating >30 Phase III trials in 2023 including 10 potential blockbusters",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f64cc4f2-7636-43e7-9d36-248e386f24b8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.28,
        "y": 0.55
      },
      "kind": "metric",
      "text": ">120 Phase II and III projects",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "196210cf-62bb-4263-8bbb-90ac604365d5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.05,
        "y": 0.3
      },
      "kind": "metric",
      "text": "12 blockbuster medicines",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "58187d03-bac0-47c2-bb2a-38b1ccc68b75",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.28,
        "y": 0.3
      },
      "kind": "metric",
      "text": "8 positive Phase III read-outs",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5b66c04b-e1fb-4e7c-b71d-b28a5540c14a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.05,
        "y": 0.55
      },
      "kind": "metric",
      "text": "34 regulatory approvals",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6fb59dcc-e26c-402b-8f98-9646b8a040c8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.03,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "1. Excluding COVID-19 medicines... 2. Including NME and major LCM approvals...",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "506f9653-d996-4556-b7c1-8d6718d5c90e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.75,
        "x": 0.04,
        "y": 0.09
      },
      "kind": "title",
      "text": "Exciting pipeline progress in FY 2022 – rapidly advancing high-potential new medicines",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "42052bd3-2ba6-44d6-a7d3-4435fe48aba8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 8,
      "from": 5,
      "beatId": "d685c806-f14d-4b04-a815-395d05c2bffb",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The deck highlights the company's strong FY 2022 results and exciting pipeline progress to address the audience's need for growth",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 20,
      "from": 5,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "6bc4b448-942a-484e-8a92-bc0a89369cb4",
      "evidence": "The deck presents a logical chain of information to support the company's growth prospects",
      "position": 0,
      "objective": "To demonstrate the company's growth potential",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}